BOSTON, April 9, 2025 -- Solu Therapeutics, a biotechnology company pioneering therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today announced the successful completion of a $41 million Series...
Art Pappas to participate in panel discussion on "The Impact of Globalization in Healthcare" at the North Carolina Biotechnology Center.
News | 08. 15. 2006
